Mogamulizumab-kpkc Intravenous and Peginterferon beta-1a Subcutaneous
Determining the interaction of Mogamulizumab-kpkc Intravenous and Peginterferon beta-1a Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: peginterferon beta-1a
Brand name: Plegridy, Plegridy Pen, Plegridy Pen Starter Pack, Plegridy Starter Pack
Synonyms: Peginterferon beta-1a, Peginterferon Beta-1a
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-PegIntron
- Mogamulizumab-kpkc Intravenous-Pegloticase
- Mogamulizumab-kpkc Intravenous-Pegloticase Intravenous
- Mogamulizumab-kpkc Intravenous-Pegvaliase
- Mogamulizumab-kpkc Intravenous-Pegvaliase-pqpz
- Mogamulizumab-kpkc Intravenous-Pegvaliase-pqpz Subcutaneous
- Peginterferon beta-1a Subcutaneous-Molindone
- Peginterferon beta-1a Subcutaneous-Mometasone (Oral Inhalation)
- Peginterferon beta-1a Subcutaneous-Mometasone and Formoterol
- Peginterferon beta-1a Subcutaneous-Mometasone and formoterol Inhalation
- Peginterferon beta-1a Subcutaneous-Mometasone Cream
- Peginterferon beta-1a Subcutaneous-Mometasone Furoate